MYPN mutations affect medication effectiveness for children with restrictive cardiomyopathy
Particularly in children, restrictive cardiomyopathy (RCM) has the poorest prognosis among heart muscle diseases. The condition can lead to heart failure, arrhythmias and sudden cardiac death, with a five-year mortality rate exceeding 70 percent.